Inventor · disambiguated record
John Sigurd Svendsen
Also filed as: SVENDSEN JOHN S · SVENDSEN JOHN SIGURD · SVENDSEN JOHN SIGURD MJOEN
21 granted patents·10 pending applications·80 citations·filing 2000–2025
93Inventor score
Top patents by PatentIndex Score
31 records- 0188US9556223B2Antimicrobial compoundsSTENSEN WENCHE·Filed 2009·Granted Jan 31, 2017·14 cites·11 claims
- 0286US11083774B2Immune checkpoint inhibitor combinationsLYTIX BIOPHARMA AS·Filed 2015·Granted Aug 10, 2021·3 cites·13 claims
- 0384US12239686B2Immune checkpoint inhibitor combinationsLYTIX BIOPHARMA AS·Filed 2024·Granted Mar 4, 2025·0 cites·14 claims
- 0481US11123398B2Chemotherapeutic combinations of cationic antimicrobial peptides and chemotherapeuticsLYTIX BIOPHARMA AS·Filed 2015·Granted Sep 21, 2021·3 cites·13 claims
- 0581US9085608B2Treatment of biofilmsSTENSEN WENCHE·Filed 2009·Granted Jul 21, 2015·12 cites·23 claims
- 0681US6890902B2Cytotoxic modified lactoferrin peptidesALPHARMA AS·Filed 2001·Granted May 10, 2005·23 cites·21 claims
- 0780US7232803B2Antimicrobial compounds and formulationsLYTIX BIOPHARMA AS·Filed 2001·Granted Jun 19, 2007·8 cites·9 claims
- 0879US8598114B2Antimicrobial compoundsSTENSEN WENCHE·Filed 2008·Granted Dec 3, 2013·8 cites·18 claims
- 0976US8143211B2Bioactive peptidesSVENDSEN JOHN SIGURD·Filed 2008·Granted Mar 27, 2012·4 cites·14 claims
- 1069US8283315B2Inhibition of tumour growthELIASSEN LIV TONE·Filed 2007·Granted Oct 9, 2012·2 cites·18 claims
- 1169US2023201305A9Immune checkpoint inhibitor combinationsLYTIX BIOPHARMA AS·Filed 2021·Application pending·0 cites
- 1269US2025332217A1Immune checkpoint inhibitor combinationsLYTIX BIOPHARMA AS·Filed 2025·Application pending·0 cites
- 1368US9241968B2Nonapeptide with anti-tumour activityHAUG BENGT ERIK·Filed 2009·Granted Jan 26, 2016·0 cites·13 claims
- 1466US8048852B2Antimicrobial compounds and formulationsLYTIX BIOPHARMA AS·Filed 2007·Granted Nov 1, 2011·0 cites·26 claims
- 1566US7439228B2Bioactive peptidesLYTIX BIOPHARMA AS·Filed 2001·Granted Oct 21, 2008·3 cites·8 claims
- 1664US11548912B2Antimicrobial compoundsPeptide Patents AS·Filed 2020·Granted Jan 10, 2023·0 cites·9 claims
- 1759US2019256558A1Antimicrobial compoundsAMICOAT AS·Filed 2019·Application pending·0 cites
- 1856US2024277890A1Antimicrobial articles comprising polyurethaneAMICOAT AS·Filed 2022·Application pending·0 cites
- 1955US2024174713A1Peptide synthesis method involving sterically hindered mixed anhydride intermediateAMICOAT AS·Filed 2022·Application pending·0 cites
- 2055US2023338609A1Medical devices and materials comprising biodegradable polyestersAMICOAT AS·Filed 2021·Application pending·0 cites
- 2153US9115169B2Method of treating tumorsSVENDSEN JOHN SIGURD·Filed 2011·Granted Aug 25, 2015·0 cites·6 claims
- 2253US9109048B2Inhibition of tumor growthELIASSEN LIV TONE·Filed 2012·Granted Aug 18, 2015·0 cites·18 claims
- 2353US2017107250A1Antimicrobial compoundsLYTIX BIOPHARMA AS·Filed 2016·Application pending·0 cites
- 2452US2023233736A1Antimicrobial formulations comprising siliconeAMICOAT AS·Filed 2021·Application pending·0 cites
- 2550US9212202B2Methods of peptide modificationSTENSEN WENCHE·Filed 2008·Granted Dec 15, 2015·0 cites·13 claims
- 2649US2016176923A1Nonapeptide with anti-tumour activityLYTIX BIOPHARMA AS·Filed 2015·Application pending·0 cites
- 2738US10231954B2Neurodegenerative therapiesLYTIX BIOPHARMA AS·Filed 2015·Granted Mar 19, 2019·0 cites·7 claims
- 2836US10927106B2Benzothiazole derivatives as DYRK1 inhibitorsPHARMASUM THERAPEUTICS AS·Filed 2017·Granted Feb 23, 2021·0 cites·15 claims
- 2935US10287320B2Anti-lymphoma peptidesUNIV I TROMSOE—NORGES ARKTISKE UNIV·Filed 2015·Granted May 14, 2019·0 cites·7 claims
- 3028US2015018311A1Therapeutic boron-containing compoundsUNIV TROMSØ·Filed 2013·Application pending·0 cites
- 3126US7393824B1Methods of peptide preparationLYTIX BIOPHARMA·Filed 2000·Granted Jul 1, 2008·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when John Sigurd Svendsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →